Larimar Therapeutics, Inc. Common Stock LRMR

$3.14 -0.95% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-29 View →
10-Q 10-Q 2026-08-04 View →
8-K 8-K 2026-08-04 View →
4 4 2026-07-08 View →
8-K 8-K 2026-06-29 View →
4 Insider transaction 2026-05-20 View →
4 4 2026-05-20 View →
4 4 2026-05-20 View →
4 4 2026-05-20 View →
4 4 2026-05-20 View →
4 4 2026-05-20 View →
8-K 8-K 2026-05-19 View →
10-Q 10-Q 2026-05-14 View →
8-K 8-K 2026-05-14 View →
DEF 14A DEF 14A 2026-04-20 View →
10-K 10-K 2026-03-19 View →
8-K 8-K 2026-03-19 View →
8-K 8-K 2026-03-09 View →
4 Insider transaction 2026-03-02 View →
4 4 2026-03-02 View →
4 4 2026-03-02 View →
4 4 2026-03-02 View →
8-K 8-K 2026-02-27 View →
424B5 424B5 2026-02-26 View →
424B5 424B5 2026-02-25 View →
8-K 8-K 2026-02-24 View →
4 4 2026-01-27 View →
4 4 2026-01-27 View →
4 4 2026-01-27 View →
4 4 2026-01-27 View →
8-K 8-K 2026-01-22 View →
8-K 8-K 2026-01-12 View →
8-K 8-K 2025-12-17 View →
8-K 8-K 2025-11-10 View →
10-Q 10-Q 2025-11-05 View →
8-K 8-K 2025-11-05 View →
8-K 8-K 2025-10-14 View →
8-K 8-K 2025-09-29 View →
10-Q 10-Q 2025-08-14 View →
8-K 8-K 2025-08-14 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$3.14
Market Cap
$329.31 million
52-Week Range
$2.71 – $6.42
Average Volume
1.22 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.